Topics

Bavencio-Inlyta combo gains EU approval for kidney cancer in adults

05:56 EDT 29 Oct 2019 | SmartBrief

Pfizer and its partner EMD Serono announced that the European Commission has approved the use of its combination therapy of B -More

Original Article: Bavencio-Inlyta combo gains EU approval for kidney cancer in adults

NEXT ARTICLE

More From BioPortfolio on "Bavencio-Inlyta combo gains EU approval for kidney cancer in adults"

Quick Search

Relevant Topics

Biotechnology Business
Alliances Astrazeneca Bioethics Boehringer Clinical Research Organization Collaborations GSK Johnson & Johnson Lilly Merck Mergers and Acquisitions Nexium Novartis Pfizer Roche Sanofi ...

Collaborations in biotechnology
Commercial and academic collaborations are used throughout the biotechnology and pharmaceutical sector to enhance research and product development. Collaborations can take the form of research and evaluation agreements, licensing, partnerships etc. ...